Skip to main content

Articles

Should Oncologists Consider Interests of Society at Large When Treating the Individual Patient?

Even When Adjusting for Improved Survival, Newer Cancer Drugs More Expensive Than Older Ones

ASCO Workgroup Proposes Consolidated Payments

Patients with Cancer Are Not Asking for Costly, Excessive Treatments

2014 Oncology Pipeline Looks Impressive

Leukemia, Oncology

Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL

Payment Reform Key to Value-Based Cancer Care

Onco360 Announces Hiring of Bill Gittinger; National Director of Managed Care

The Social Impact of Rosacea, Patterns of Care, and Associated Costs Featured at AAD 2014

AAD 2014 Highlights: Understanding Inflammation Markers and Treating Erythema in Rosacea

Page 148 of 244
Results 1471 - 1480 of 2434